Selling the Value of Drug Safety Communicating more effectively the benefits of pharmacovigilance to patients, providers and physicians.
Five Key Trends: The Complete Conversation Discussing key findings from the research report, "Benchmarking Drug Safety and Pharmacovigilance."
Outsourcing as a Matter of Preference Exploring the different ways pharmaceutical organizations outsource their drug safety programs.
Matching Expectations with Budgets Appropriate planning and building a budget to accommodate quality and risk mitigation strategies.
Variances in Drug Safety Department Sizes & Budgets Costs and balancing the benefits of in-house vs. outsourced pharmacovigilance resources.
Opening Lines of Communication with the FDA Helping sponsors gain clarity from vague regulator guidance through open communications.
